GUARD – Estrogen & Gynecomastia Blocker (Raloxifene)

Advanced SERM Formula for Estrogen Control & Gyno Reversal

GUARD is a research-grade Selective Estrogen Receptor Modulator (SERM) featuring Raloxifene, widely considered one of the most effective compounds for combating gynecomastia, especially in its later stages. Unlike Tamoxifen, which is typically used for early gyno intervention, Raloxifene has demonstrated the ability to reduce long-standing pubertal gynecomastia, making it the go-to choice for serious estrogen management.

Originally developed for osteoporosis and breast cancer prevention, Raloxifene works by blocking estrogen receptors in breast tissue, without lowering estrogen systemically. This makes it ideal for on-cycle support, post-cycle therapy (PCT), or standalone use to reverse or prevent gynecomastia caused by elevated estrogen.

💊 Key Ingredient:

• Raloxifene – A potent second-generation SERM

  • Selectively blocks estrogen activity in breast tissue

  • Supports testosterone levels indirectly by reducing estrogenic feedback

  • More effective than Tamoxifen for chronic or stubborn gynecomastia

✅ Why Choose GUARD?

• Clinically proven ingredient (Raloxifene) for estrogen control

• Reverses existing gynecomastia, even long-term cases

• Prevents estrogen-related side effects during or after cycle

• Ideal for on-cycle estrogen management or PCT support

• Non-suppressive to testosterone production

• Orally dosed, easy to integrate into any protocol

📦 Use Cases:

• Managing or reversing pubertal or cycle-induced gyno

• Supporting hormonal balance during steroid/SARM cycles

• Post-cycle therapy (PCT) to maintain lean gains

• Estrogen control without the need for harsh AI compounds